These suggested that MASTL-mediated tumor progression was dependent on the tumor-suppressive action of PP2A, as PP2A dephosphorylates many oncogenic factors involved in the process of cellular transformation, such as c-Myc (35). The gene discussed is MASTL; the disease is neoplasm.